Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-23-000027
Filing Date
2023-08-03
Accepted
2023-08-03 16:04:10
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20230630.htm   iXBRL 10-Q 1485438
2 EX-31.1 exhibit3116302023.htm EX-31.1 9147
3 EX-31.2 exhibit3126302023.htm EX-31.2 9092
4 EX-32.1 exhibit3216302023.htm EX-32.1 8224
10 mrna-20230630_g1.jpg GRAPHIC 63925
11 mrna-20230630_g2.jpg GRAPHIC 609503
  Complete submission text file 0001682852-23-000027.txt   10070928

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20230630.xsd EX-101.SCH 54209
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20230630_cal.xml EX-101.CAL 112805
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20230630_def.xml EX-101.DEF 218527
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20230630_lab.xml EX-101.LAB 663471
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20230630_pre.xml EX-101.PRE 438945
86 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20230630_htm.xml XML 1591121
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 231139808
SIC: 2836 Biological Products, (No Diagnostic Substances)